While it is well-recognized that prostate cancer has a significant heritable component, the role of genetics in disease prediction, diagnosis and treatment is gaining increased attention. In his dual role of urologic oncologist and geneticist, Keyan Salari, MD, PhD, urologic surgeon at the Massachusetts General Hospital Department of Urology and urologic oncologist with the Mass General Cancer Center, is exploring the genetic drivers of prostate cancer through a new clinic and extensive research.